DNA Methylation in Schizophrenia

Adv Exp Med Biol. 2017:978:211-236. doi: 10.1007/978-3-319-53889-1_12.

Abstract

Schizophrenia is a highly heritable psychiatric condition that displays a complex phenotype. A multitude of genetic susceptibility loci have now been identified, but these fail to explain the high heritability estimates of schizophrenia. In addition, epidemiologically relevant environmental risk factors for schizophrenia may lead to permanent changes in brain function. In conjunction with genetic liability, these environmental risk factors-likely through epigenetic mechanisms-may give rise to schizophrenia, a clinical syndrome characterized by florid psychotic symptoms and moderate to severe cognitive impairment. These pathophysiological features point to the involvement of epigenetic processes. Recently, a wave of studies examining aberrant DNA modifications in schizophrenia was published. This chapter aims to comprehensively review the current findings, from both candidate gene studies and genome-wide approaches, on DNA methylation changes in schizophrenia.

Keywords: DNA methylation; Epigenetics; Psychosis; Schizophrenia.

Publication types

  • Review

MeSH terms

  • Brain-Derived Neurotrophic Factor / genetics
  • Brain-Derived Neurotrophic Factor / metabolism
  • Case-Control Studies
  • Cognition Disorders / genetics
  • DNA Methylation / genetics*
  • DNA Methylation / physiology
  • Epigenesis, Genetic / genetics*
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Humans
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Neurotransmitter Agents / genetics
  • Neurotransmitter Agents / metabolism
  • Psychotic Disorders / genetics
  • Schizophrenia / genetics*
  • Schizophrenia / metabolism

Substances

  • Brain-Derived Neurotrophic Factor
  • Nerve Tissue Proteins
  • Neurotransmitter Agents
  • BDNF protein, human